SAVE THE DATE!
February 27, 2017
The 2016 Election: How Will It Affect the US Health Care Industry?
Donald Trump’s election combined with Republican control of Congress signals that major changes in healthcare policy are likely. The debate in Washington is already changing as policymakers consider the implications of repealing the Affordable Care Act (ACA) with no consensus on a replacement strategy. This creates substantial uncertainty for US healthcare organizations that have spent the past 6 years preparing to compete successfully in a new environment created by the ACA. This Forum will review the policy options under consideration as they stand a month after Donald Trump’s inauguration. We will then convene three panels to discuss the outlook for insurers, health systems, and pharmaceutical and device firms under leading reform options and discuss industry perspectives on potentially viable approaches.
Stuart Altman, Ph.D., Professor of National Health Policy, Brandeis University
Joseph Antos, Wilson H. Taylor Scholar, American Enterprise Institute
Len Nichols, Professor of Health Policy, George Mason University
Matt Eyles, Executive VP, Policy and Regulatory Affairs, AHIP
Jim Ricciutti, Vice President, Public Affairs and Public Policy, Aetna
Steve Parente, Professor, University of Minnesota
Chip Kahn, President and CEO, Federation of American Hospital Systems
Liz Fowler, Vice President, Global Health Policy, Johnson & Johnson (invited)
Parashar Patel, Vice President Global Health Policy, Boston Scientific
Barbara Walters MD, Executive Vice President, Trinity Health
Shawn Martin, Senior VP, American Academy of Family Physicians
Cybele Bjorklund, Head of Policy, Sanofi
Sabrina Corlette JD, Research Professor, Center on Health Insurance Reforms, Georgetown University